New hope for elderly myeloma patients: talquetamab trial opens
Disease control
Recruiting now
This study tests a drug called talquetamab in elderly patients whose multiple myeloma has come back after earlier treatments. The drug helps the body's immune cells attack the cancer. If the drug stops working, another drug called daratumumab may be added. The goal is to see if t…
Phase: PHASE2 • Sponsor: Larysa Sanchez • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC